Table 1.
Compounds | Functions | Repositioning Methods | Target Fungi | References |
---|---|---|---|---|
Bithionol | Anti-parasitic drug | High-throughput ATP content assays | Exserohilum rostratum | [39] |
Tacrolimus | Immunosuppressive agent | The same as above | E. rostratum | [39] |
Floxuridine | Antimetabolite | The same as above | E. rostratum | [39] |
Auranofin | Rheumatoid arthritis drug | Clinical & Laboratory Standard Insitute (CLSI) M27-A3 protocol | Candida and Cryptococcus strains | [40] |
Auranofin | Rheumatoid arthritis drug | CLSI M27-A3 (for yeast) & M38-A2 (for filamentous fungi) protocols |
Aspergillus fumigatus, Scedosporium apiospermum, Lomentospora prolificans, Candida albicans, Candida krusei, Cryptococcus neoformans |
[41] |
Drospirenone | Synthetic hormone (birth control pills) w/ethinylestradiol | Enhancement of amphotericin B/caspofungin activity against Candida albicans biofilms (96-well plate assay) |
C. albicans, Candida glabrata |
[42] |
Perhexiline | Anti-anginal agent | The same as above | The same as above | [42] |
Toremifine | Selective oestrogen receptor modulator (Oestrogen receptor-positive breast cancer treatment) | The same as above | The same as above | [42] |
Aspirin (Acetyl salicylic acid) |
Anti-pain, fever, or inflammation drug | European Committee on Antimicrobial Susceptibility Testing (EUCAST) protocol |
C. neoformans, Cryptococcus gatti |
[43] |
Ibuprofen | Nonsteroidal anti-inflammatory drug | The same as above | The same as above | [43] |
Human glycogen synthase kinase 3 (GSK-3) inhibitors | Neurological disorder drug | 24-well plate assay | A. fumigatus | [44] |
Octodrine from Johns Hopkins Clinical Compound Library version 1.0. | Decongestant drug | CLSI M44-A2 protocol | C. albicans | [45] |
Amiodarone from Prestwick library (Off-patent, biologically active molecules) | Antiarrhythmic drug | High-throughput adenylate kinase assay | C. neoformans | [46] |
Thioridazine | Antipsychotic drug | The same as above | C. neoformans | [46] |
Artesunate from Pharmakon 1600 repositioning library | Antimalarial drug | Miconazole synergy test (Anti-biofilm testing) | C. albicans | [47] |
Hexachlorophene | Anti-infective (topical) drug | The same as above | C. albicans | [47] |
Pyrvinium pamoate | Antihelmintic drug | The same as above | C. albicans | [47] |
Quinacrine | Anti-protozoan drug | 96-well plate anti-biofilm testing | C. albicans | [48] |
Cyclo-Phosphamide (plus 28 drugs) |
Anti-cancer drug | 96-well anti-filamentation assay | C. albicans | [49] |
Tosedostat from the Enzo & the Institute for Molecular Medicine Finland oncology collection libraries | Anti-cancer (Aminopeptidase inhibitor) drug | EUCAST protocol. |
C. albicans, C. glabrata |
[14] |
Chloroquine | Anti-malarial drug | Microtiter well plate yeast-to-hyphae transition assay | C. albicans | [50] |
Aliskiren | Anti-hypertensive drug | CLSI M27-A2 protocol | C. albicans | [51] |
Atorvastatin | Anti-hypercholestero-laemia drug | CLSI M27-A3 protocol | C. gatti | [52] |
P21-activated protein kinase inhibitor | Anti-thyroid cancer drug | Agar plate bioassay |
Fusarium oxysporum, Fusarium graminearium, Phytopthora sp., Myrothecium roridum, Helminthosporium maydis. |
[53] |